Working... Menu

A Clinical Study in Subjects With Huntington's Disease to Assess Efficacy and Safety of Three Oral Doses of Laquinimod (LEGATO-HD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02215616
Recruitment Status : Completed
First Posted : August 13, 2014
Last Update Posted : October 9, 2018
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Branded Pharmaceutical Products, R&D Inc. )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 19, 2018
  Actual Study Completion Date : June 19, 2018